The Pershing Square Sohn Cancer Research Alliance is dedicated to playing a catalytic role in accelerating cures for cancer by enabling the pursuit of the most innovative and advanced cancer research and by facilitating collaborations between science and business.
The Prize for young investigators provides early-stage funding opportunities to New York scientists with innovative ideas in cancer research. The program surrounding the Prize is a catalyst in bridging the gap between the academic scientific community and the business community.
DANIEL BACHOVCHIN, PHD
KIVANC BIRSOY, PHD
ALBERTO CICCIA, PHD
CAMILA DOS SANTOS, PHD
BENJAMIN GREENBAUM, PHD
DAN LANDAU, MD, PHD
BENJAMIN MARTIN, PHD
NEW YORK (PR Businesswire) – The Pershing Square Sohn Cancer Research Alliance (PSSCRA) today announced the opening of applications for its 2019 Prize for Young Investigators in Cancer Research. The prize of $200,000 per year for up to three years is awarded annually to at least six New York City area-based scientists. The prize empowers researchers to pursue innovative, high-risk/high-reward cancer research at a stage when traditional funding is lacking. Applicants must have between two to eight years of experience running their own laboratories by the award start-date (July 2019) and hold a PhD, MD or MD-PhD (or degree equivalent). The deadline to submit a Letter of Intent is November 5, 2018. For more details on PSSCRA and the application process, including the full eligibility criteria, please visit: https://psscra.org/application/.
On Tuesday, October 23rd, 2018, the Pershing Square Sohn Cancer Research Alliance held its Second Annual Pershing Square Sohn Retreat in Nicholls-Biondi Hall at Cold Spring Harbor Laboratory in Long Island. The Retreat gave the 2015 Pershing Square Sohn Prize winners, who had just finished their final year of funding, the chance to present their work performed over the past three years to their peers and mentors.
Bill Ackman, Co-Founder. The Pershing Square Foundation